Insights archive | Sagentia Innovation

Insights archive

Webinar: Future of molecular diagnostics: in home testing and liquid biopsy

Molecular diagnostics has seen significant developments in two different directions over the last 12 months: Liquid...

FDA IVD review process has changed; how should manufacturers adapt?

A surge in premarket submissions during Covid-19 led the FDA to realign its review process for IVDs. Consequently, many...

Webinar: Taking the assay from lab to product

Steve Brown and Nick Collier share 9 top learnings when designing and developing diagnostic Point of Care assays from...

Webinar: Automating FFPE sample preparation for faster diagnostics and greater accessibility

Recently Nick Collier, Sagentia Medical CTO has been considering how easy to use cartridge-based instruments could be...

Webinar: Moving treatments from hospital to home: Dialysis, COVID-19 and the step change

In a recent webinar, Chis Humby and Carl Hewett discussed how treatments such as dialysis could be moved from a...

Optimizing Covid-19 isolation: the role of virus testing and the technology requirements

As work, education and recreation resume following Covid-19 restrictions, further isolation regimes must be...

What’s next on the Point-of-Care Testing Menu?

From SARS-CoV-2 to cardiac biomarkers, a steady stream of IVD innovation shows no signs of letting up Article published...

Improving dialysis in the home

By Chris Humby, Vice-President Medical at Sagentia Statistics surrounding chronic kidney disease (CKD) make sobering...

The highs and lows of turbidimetry: assessing its suitability for point of care immunoassays

Turbidimetry is an attractive option for point of care immunoassay diagnostic devices because of its simplicity...
Get in touch